Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Deferred Income Tax

The difference between tax expense recognized and tax actually paid in cash during the period.

No reported Deferred Income Tax figures are available to summarize.

Deferred Income Tax history

Currency unavailable · from the cash flow

No Deferred Income Tax data reported for this period type.

Deferred Income Tax vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Deferred Income Tax for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RNAAtrium Therapeutics, Inc.FY2025$142K USD——0.8%
CYTKCytokinetics, IncorporatedLTM Jun 2026$0 USD——0.0%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$0 USD——0.0%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$0 USD———
TNYATenaya Therapeutics, Inc.LTM Mar 2026$0 USD——0.0%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) ———0.0%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.